Fulcrum Therapeutics Inc (FULC)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Bryan E. Stuart |
| Employees: | 100 |
| Web site: | fulcrumtx.com |
|
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
617-651-8851
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Fulcrum Therapeutics, Inc. focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin.
Please log in first to see chart